Análisis Argos
HUM
HUMCara
Humana Inc. · Healthcare
US$ 396.75
precio al 2026-07-04
Valor justo Argos*
US$ 262–287
vs. su valor justo
38% por encima
Score Argos
30/100
LA RESPUESTA
El mercado le pide crezca 15% al año — más de lo que ha demostrado (3.4%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Sin recompensas destacadas.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Balance frágil: la deuda pesa sobre el negocio.
VALOR2/6FUTURO3/6PASADO2/6SALUD1/6DIVIDENDO2/6
El Iris de calidad
VALOR2/6FUTURO3/6PASADO2/6SALUD1/6DIVIDENDO2/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance frágil
DividendoRetorno al accionista moderado
Score Argos30de 100Cara
Ingresos10%
US$ 129.7 B
Margen operativo21%
1.1%
Flujo de caja libre84%
US$ 0.4 B
Deuda neta
US$ 8.7 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 47.6B
P/E40.1x
EV/EBITDA24.8x
FCF yield0.8%
ROIC4.6%
Margen operativo1.1%
Crecim. ingresos+10.1%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

gurufocus.com · 3 jul
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026
prnewswire.com · 3 jul
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
businesswire.com · 30 jun
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. The 2026 national grants scale the Foundati.
prnewswire.com · 30 jun
Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers and providers as Dario moves closer to care O'Reilly's track record of leveraging advanced data analytics and AI in supporting value-based care strongly aligned with Dario's AI transition NEW YORK, June 30, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.
zacks.com · 29 jun
How CenterWell Is Driving Humana's Growth Beyond Insurance
CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.
reuters.com · 29 jun
Swedish care provider Ambea makes recommended $304 million offer for Humana
Swedish care provider Ambea said on Monday it had made a recommended public ​offer for peer Humana , valuing the ‌company at about 2.96 billion Swedish crowns ($304.13 million).
zacks.com · 24 jun
Can Humana's Margin Recovery Drive Long-Term Earnings Growth?
HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.
gurufocus.com · 23 jun
Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales
Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.